Califf Likely To Find Many Familiar Problems Upon Return To US FDA Helm

President Biden’s pick for FDA commissioner should remember many of the hot-button issues that he would face upon confirmation, such as drug pricing and approval standards.

Robert Califf
As he did here in 2015, Robert Califf will appear before the Senate HELP Committee after President Biden nominates him for a second term as FDA commissioner. • Source: Reuters/Gary Cameron

More from Regulation

More from Policy & Regulation